Do vasopressin receptor type 2 antagonists have therapeutic potential in polycystic kidney diseases?

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.4, 2004-04, pp. : 431-434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential of Vasopressin Receptor Antagonists

By Ali Farhan Guglin Maya Vaitkevicius Peter Ghali Jalal K.

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 847-858

Adis International

Access to resources Recommend Favorite

Vasopressin Receptor Antagonists: Therapeutic Potential in the Management of Acute and Chronic Heart Failure

By Russell S.D. DeWald T.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 1, 2003-01 ,pp. : 13-20

Adis International

Access to resources Recommend Favorite

The therapeutic potential of vasopressin receptor antagonists in congestive heart failure

By Salam Amar M

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 687-691

Informa Healthcare

Access to resources Recommend Favorite

A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases

By Arulkumaran Nishkantha Unwin Robert J Tam Frederick WK

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 7, 2011-07 ,pp. : 897-915

Informa Healthcare

Access to resources Recommend Favorite

Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists

By Thibonnier M.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 729-740

Informa Healthcare

Access to resources Recommend Favorite